ARCHIVES

Brigham & Women’s Suspends Controversial Morcellation Study As Apparent “Difference of Opinion” with FDA Comes to Light

This article is from The Cancer Letter archive.

Vol. 40 No. 45 | December 5, 2014

Download PDF Visit The Full Archive

Related Articles

Biomarker Identified Predicting Graft-Versus-Host Disease Risk

August 30, 2013

Shalala Named President, University Of Miami.

November 24, 2000

Competing Strategies For Breast Cancer? Brinker Tries to Ensure acceptance Of Report, Visco Urges Broad Effort

October 8, 1993

Montefore Oncology Dept. Writes In Support of Peter Wiernik

November 12, 1993

Obituary: Ruth Kirschstein, 82, NIH Administrator, Scientist, Mentor. House Member Softens Breast Cancer Bill

October 9, 2009

Chabner Cautions Against Downsizing, Consolidation Of NCI Intramural Programs

March 3, 1995